Browse Related Topics For:

Biologics

196
Pharmaceutical Industry
174
FDA
152
Biosimilars
111
Patents
105
Pharmaceutical Patents
104
BPCIA
95
Prescription Drugs
76
Patent Infringement
63
Patent Litigation
63
Sandoz v Amgen
60
Amgen
49
Sandoz
45
Patent Dance
43
Medical Devices
33
Commercial Marketing
33
SCOTUS
30
FDA Approval
30
Notice Requirements
28
CMS
27
Generic Drugs
24
Healthcare
24
Medicare
22
Life Sciences
22
Trans-Pacific Partnership
21
Preliminary Injunctions
20
Popular
19
Affordable Care Act
19
Declaratory Judgments
19
Inter Partes Review (IPR) Proceeding
19
Medicaid
18
Biotechnology
17
Biologics Price Competition and Innovation Act of 2009
16
Draft Guidance
15
Appeals
13
Manufacturers
12
Health Care Providers
12
Intellectual Property Protection
12
Sunshine Act
11
Comment Period
11
Hospira
10
aBLA
10
Clinical Trials
10
Drug Pricing
10
EU
10
Physicians
9
Apotex
9
FDCA
9
FTC
9
Genentech
9
Hatch-Waxman
9
Innovation
9
IP License
9
Patent Applications
9
Patent-Eligible Subject Matter
8
GPOs
8
Labeling
8
Legislative Agendas
8
Medicare Part B
8
Patent Trial and Appeal Board
8
Pfizer
8
Proposed Legislation
8
Public Health Service Act
8
Trade Agreements
8
Trump Administration
8
USPTO
7
ANDA
7
Certiorari
7
Medical Supplies
7
Payment Records
7
Preemption
7
Product Exclusivity
7
Product Labels
7
Proposed Regulation
6
Canada
6
Cancer
6
CHIP
6
Health Insurance
6
Pharmacies
6
Regulatory Standards
6
Reporting Requirements
5
AbbVie
5
Covered Recipients
5
Department of Veterans Affairs
5
Final Rules
5
GAO
5
HHS
5
Hospitals
5
Interchangeability
5
License Applications
5
Long Term Care Facilities
5
Medical Research
5
New Legislation
5
PHSA
5
Physician Medicare Reimbursements
5
Research and Development
5
Skilled Nursing Facility
5
Solicitor General
5
State Law Claims
5
Summary Judgment
5
Vaccinations
5
World Health Organization
4
ACOs
4
Barack Obama
4
Celltrion
4
Exclusivity
4
Final Guidance
4
First Amendment
4
Genetic Materials
4
Healthcare Reform
4
HELP
4
Injunctive Relief
4
Intellectual Property Litigation
4
Investigational New Drug Application (IND)
4
Licensing Rules
4
Mylan Pharmaceuticals
4
Myriad
4
OIG
4
Patent Term Extensions
4
Patient Safety
4
Petition for Writ of Certiorari
4
Pharmacist
4
Public Comment
4
Purple Book
4
REMS
4
Teaching Hospitals
4
Unfair Competition
3
Applicable Manufacturers
3
Australia
3
Automotive Industry
3
Calculation of Damages
3
CETA
3
Competition
3
Continuing Medical Education
3
Data Protection
3
Declaratory Relief
3
Disclosure Requirements
3
Dispute Resolution
3
DOJ
3
Drug Safety
3
EPA
3
Extrapolation
3
Fast Track Process
3
FD&C Act
3
Federal Budget
3
Federal Register
3
Guidance Update
3
HCPCS
3
Health Canada
3
Hospice
3
Imports
3
Inpatient Rehab Facilities
3
ITC
3
Janssen Pharmaceuticals
3
Medicare Access and CHIP Reauthorization (MACRA)
3
Medicare Advantage
3
Medicare Part D
3
Merck
3
NAFTA
3
Native American Issues
3
New Guidance
3
NIH
3
Obama Administration
3
Obviousness
3
Orphan Drugs
3
Patent Invalidity
3
Pending Legislation
3
Personal Jurisdiction
3
PHRMA
3
Physician Payments
3
Prior Art
3
Public Hearing
3
Regulatory Oversight
3
Remedies
3
Safe Harbors
3
Section 337
3
Teva Pharmaceuticals
3
Tobacco Regulations
3
TRIPS Agreement
3
Veterans
2
21st Century Cures Initiative
2
Allergan Inc
2
Alternative Payment Models (APM)
2
Amarin
2
AMP v Myriad
2
Animal Drugs
2
Anti-Competitive
2
Anti-Kickback Statute
2
Bayer
2
Biogen Idec
2
Biopharmaceutical
2
CADTH
2
CDC
2
CGMP
2
China
2
Citizen Petitions
2
Coherus
2
Common Ownership
2
Confidential Information
2
Conversion
2
CVS
2
Diagnostic Tests
2
Disclosure
2
Discovery
2
Dismissals
2
EHR
2
Eli Lilly
2
European Commission
2
European Patent Office
2
Expert Testimony
2
Exports
2
FFDCA
2
Fraud and Abuse
2
Genzyme
2
GM/Synbio Algae Project
2
Health Information Technologies
2
Healthcare Facilities
2
Home Healthcare Workers
2
HRSA
2
Inpatient Prospective Payment System (IPPS)
2
International Harmonization
2
IRS
2
Leave to Appeal
2
Life Technologies Corp v Promega Corp
2
Marketing
2
Medical Malpractice
2
Mergers
2
Monopolization
2
Negotiations
2
Off-Label Promotion
2
OMB
2
Opioid
2
Oral Argument
2
Over-the-Counter Sales
2
PDUFA
2
Plant Patents
2
PMNOC Regulations
2
Post-Grant Review
2
Psychiatric Hospitals
2
Public Health Insurance Marketplace
2
Qualified Health Plans
2
Right to Try
2
SAMHSA
2
Samsung
2
Sanofi
2
Sanofi-Aventis
2
Scientific Evidence
2
Section 271
2
Settlement
2
State Budgets
2
Supreme Court of Canada
2
Tax Credits
2
TC Heartland LLC v Kraft Foods
2
Telecommunications
2
Telehealth
2
The Enlarged Board of Appeals
2
Toxic Exposure
2
Trade Secrets
2
Trade Unions
2
Trademarks
2
Transfers of Value
2
Transparency
2
Unjust Enrichment
2
Vacated
2
Value-Based Purchasing
2
Venue
2
Wage and Hour
2
Zika
1
1099s
1
21st Century Cures Act
1
35 U.S.C. § 271(e)(1)
1
510(k) RTA
1
Abuse of Process
1
Acquisitions
1
Administrative Proceedings
1
Admissible Evidence
1
Admissions
1
Advertising
1
Advisory Committee
1
Advisory Opinions
1
Affordable Housing
1
All Writs Act
1
Amended Regulation
1
Amended Rules
1
America Invents Act
1
American Health Care Act (AHCA)
1
Amgen v Sandoz
1
Amicus Briefs
1
Animal Patents
1
Anticipation
1
Anticompetitive Agreements
1
Antitrust Investigations
1
Antitrust Violations
1
Applications
1
Arbitration
1
Asbestos
1
Asbestos Litigation
1
Assisted Living Facility
1
AstraZeneca
1
Attorney Generals
1
Australian Patent Office
1
Bad Debt
1
Bayh-Dole Act
1
Big Data
1
Billing
1
Biobased Chemicals
1
Bipartisan Budget
1
Boehringer
1
BRCA
1
Bristol-Myers Squibb
1
BsUFA
1
Build America Investment Initiative
1
Bulk Purchasing
1
Burden of Proof
1
Cadillac Tax
1
Carbon Taxes
1
Caregivers
1
CCIIO
1
Cell Towers
1
Center for Drug Evaluation and Research (CDER)
1
Certificates of Supplementary Protection (CSPs)
1
Chamber of Commerce
1
Charitable Organizations
1
Chemicals
1
China FDA
1
Chrysler
1
Civil Conspiracy
1
Classifications of Goods
1
CLIA
1
Clinical Evaluations
1
Clinical Laboratory Testing
1
CLS Bank v Alice Corp
1
CME
1
Commercial Insurance Policies
1
Compensatory Awards
1
Competition Authorities
1
Congressional Committees
1
Consent
1
Constitutional Challenges
1
Content Marketing
1
Continuing Care Retirement Communities
1
Continuing Resolution
1
Controlled Substances
1
Controlled Substances Act
1
Copyright
1
Corporate Counsel
1
Corporate Integrity Agreement
1
Country of Origin
1
Covered Business Method Patents
1
Covered Entities
1
Covered Products
1
CREATE Act
1
Cross Motions
1
Cross-Border Transactions
1
Cross-Complaints
1
Currency Manipulation
1
Cybersecurity
1
DaimlerAG
1
DaimlerChrysler v Bauman
1
Dairy Farmers
1
Damages
1
Data Collection
1
Databases
1
DEA
1
Decision-Making Process
1
Decriminalization of Marijuana
1
Deficit Reduction
1
Dentists
1
Design Defects
1
Device Classification
1
Diagnostic Imaging Services
1
Diversity Jurisdiction
1
Double Patent
1
DQSA
1
Drug Approvals
1
Drug Compounding
1
Drug Treatment
1
DSCSA
1
DSRIP
1
E-Commerce
1
Earnings Reports
1
Economic Development
1
Electronic Medical Records
1
Electronic Records
1
Employer Group Health Plans
1
Employer Mandates
1
Employer Payment Plans
1
En Banc Review
1
Energy Sector
1
Energy Storage
1
Energy-Efficiency Tax Credits
1
Enforcement
1
Enforcement Actions
1
Environmental Policies
1
ERISA
1
Escrow Accounts
1
European Medicines Agency (EMA)
1
European Patent Convention
1
Evidence
1
Exclusive Dealing Agreements
1
Exclusive Licenses
1
Exclusive Use
1
Exclusivity Clauses
1
Failure To Warn
1
False Claims Act (FCA)
1
FDA Reauthorization Act
1
FDARA
1
FDASIA
1
Federal Supply Schedule (FSS)
1
Filing Deadlines
1
Financial Institutions
1
Food and Drug Modernization Act
1
Food Manufacturers
1
Ford Motor
1
Foreign Manufacturers
1
Forum Selection
1
France
1
Fraudulent Joinder
1
Free Speech
1
FTC v Actavis
1
GATT
1
GDUFA
1
General Jurisdiction
1
General Motors
1
General Wellness Devices
1
Generic
1
Genetically Engineered Animals
1
Genome Project
1
Global Economy
1
Good Faith
1
Government Studies
1
Governor Brown
1
Governor Malloy
1
HCEI
1
HDHPs
1
Health & Safety Standard
1
Health IT
1
Health Savings Accounts
1
Healthcare Fraud
1
Healthcare.gov
1
Hillary Clinton
1
HIPAA
1
HIPAA Audits
1
Hoffman LaRoche
1
Home Health Agencies
1
Home Health Care
1
Human Genes
1
Human Trafficking
1
Impression Products v Lexmark International
1
Indemnity Insurance
1
Independent Contractors
1
Indian Health Service (IHS)
1
Individual Mandate
1
Information Sharing
1
Informed Consent
1
Inherent Disclosure Doctrine
1
Injunctions
1
Innovation Act
1
Innovative Technology
1
Innovator Liability
1
Inpatient Quality Reporting
1
Interlocutory Appeals
1
Internet
1
Investigations
1
Ireland
1
Irreparable Harm
1
Johns Hopkins
1
Johnson & Johnson
1
Joinder
1
Laboratories
1
Legislative Riders
1
Licenses
1
Lifeline Program
1
Long-Term Care
1
Lost Profits
1
Manufacturing Defects
1
Marketing Authorization Application
1
Mayo v. Prometheus
1
Meaningful Use
1
Medicaid Expansion
1
Medicaid Reimbursements
1
Medical Device Tax
1
Medical Device User Fee Program (MDUFA IV)
1
Medical Liability
1
Medical Licensure Compact
1
Medical Marijuana
1
Medical Reimbursement
1
Medicines and Healthcare Products Regulatory Agency (MHRA)
1
MedPAC
1
Mental Health
1
Minimum Wage
1
Misappropriation
1
Mobile Health Apps
1
Mobile Medical Applications
1
Mootness
1
Mortgages
1
Motion for Leave
1
Motion to Compel
1
Motion to Dismiss
1
Motion To Stay
1
Motion To Strike
1
Motion to Terminate
1
National Evaluation System for Health Technology (NEST)
1
Net Metering
1
New Regulations
1
Notice and Comment
1
Novartis
1
Nurses
1
Nursing Homes
1
Off-Label Use
1
Ombudsman
1
On-Sale Bar
1
Orange Book
1
Organ Donation
1
OSTP
1
OTC
1
Out of Network Provider
1
Out-of-Pocket Expenses
1
Outsourcing
1
Paid Family Leave Law
1
Patent Exhaustion
1
Patent Expiration
1
Patent Filings
1
Patent Prosecution
1
Patent Reform
1
Patent Term Adjustment
1
Patent Terms
1
Patent Trolls
1
Patent Validity
1
Patented Medicine Prices Review Board (PMPRB)
1
Patient Assistance Programs
1
Patient Rights
1
Patient Self-Referral
1
PCORI
1
Pediatrics
1
Penalties
1
Permanent Injunctions
1
Personalized Medicine
1
Phishing Scams
1
Physician Fee Schedule
1
Physician Ownership
1
Physician SGR Formula
1
Physician-Assisted Suicide
1
Political Debates
1
Post-Market Approval
1
Power Grid
1
Pregnancy Discrimination
1
Premarket Approval Applications
1
Preponderance of the Evidence
1
Prescription Drug Coverage
1
Press Releases
1
Principal Place of Business
1
Private Right of Action
1
Product Defects
1
Product of Nature Doctrine
1
Professional Conferences
1
Proposed Rules
1
Provider Payments
1
Public Health
1
Public Meetings
1
Public Policy
1
Public Safety
1
Quality Control Plan
1
Real Party in Interest
1
Reasonable Accommodation
1
Reimbursements
1
Remuneration
1
Repeal
1
Replacement Value
1
Research Funding
1
Retirement Plan
1
Rollbacks
1
Rural Areas
1
Rural Development
1
Rural Health Care Program
1
Russia
1
Safety Precautions
1
Scientific Research
1
Secretary of HHS
1
Section 340B
1
Sexual Assault
1
SFDA
1
Sherman Act
1
Small Business
1
Social Media
1
Social Media Policy
1
Software
1
Specialty Healthcare
1
Specific Jurisdiction
1
Standard of Care
1
Standing
1
Stark Law
1
Startups
1
State Health Insurance Exchanges
1
State of Incorporation
1
Statute of Limitations
1
Stem cells
1
STRONG Patents Act
1
Students
1
Subject Matter Conflicts
1
Suicide
1
Supply Chain
1
Tariffs
1
Technology
1
Telemarketing
1
Telemedicine
1
Terminal Illness Treatments
1
Teva v Sandoz
1
The Common Rule
1
The Patent Act
1
Third-Party
1
Tobacco Litigation
1
Tolling
1
Toxic Substances Control Act (TSCA)
1
Trade Policy
1
Trade Promotion Agreements
1
Trade Promotion Authority
1
Trade Relations
1
Trademark Infringement
1
Traumatic Brain Injuries
1
Treaties
1
U.S. House
1
UK
1
Unfair Labor Practices
1
Unions
1
US Trade Policies
1
USDA
1
User Fees
1
Utility Patents
1
Warning Labels
1
Warranties
1
Water
1
Webinars
1
Websites
1
Wrongful Death
1
WTO
1
Young Lawyers